10.52
price up icon2.14%   0.22
after-market Handel nachbörslich: 10.49 -0.03 -0.29%
loading

Greenwich Lifesciences Inc Aktie (GLSI) Neueste Nachrichten

pulisher
01:38 AM

Analyzing Greenwich LifeSciences Inc. with risk reward ratio chartsMarket Activity Report & Fast Exit Strategy with Risk Control - newser.com

01:38 AM
pulisher
Oct 13, 2025

What recovery options are there for Greenwich LifeSciences Inc.Portfolio Update Report & Verified Momentum Stock Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What MACD and RSI say about Greenwich LifeSciences Inc.Weekly Stock Analysis & Verified Chart Pattern Signals - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How hedge fund analytics apply to Greenwich LifeSciences Inc. stockTrade Analysis Report & Verified Swing Trading Watchlist - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What institutional flow reveals about Greenwich LifeSciences Inc.Quarterly Trade Review & Free Accurate Trade Setup Notifications - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Why Greenwich LifeSciences Inc. stock is seen as undervalued2025 EndofYear Setup & Safe Entry Zone Tips - newser.com

Oct 13, 2025
pulisher
Oct 11, 2025

Greenwich LifeSciences, Inc.Common stock (NQ: - FinancialContent

Oct 11, 2025
pulisher
Oct 10, 2025

Is Greenwich LifeSciences Inc. building a consolidation basePortfolio Return Report & Low Volatility Stock Suggestions - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Can Greenwich LifeSciences Inc. stock hit analyst price targetsJuly 2025 Update & High Accuracy Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Greenwich LifeSciences expands breast cancer trial to Austria By Investing.com - Investing.com Canada

Oct 09, 2025
pulisher
Oct 09, 2025

Greenwich LifeSciences expands breast cancer trial to Austria - Investing.com India

Oct 09, 2025
pulisher
Oct 09, 2025

Greenwich Lifesciences announces addition of Austria to FLAMINGO-01 clinical trial - MarketScreener

Oct 09, 2025
pulisher
Oct 09, 2025

Greenwich LifeSciences Expands Phase III FLAMINGO-01 Clinical Trial to Austria - Quiver Quantitative

Oct 09, 2025
pulisher
Oct 09, 2025

Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial - GlobeNewswire

Oct 09, 2025
pulisher
Oct 06, 2025

Greenwich LifeSciences Inc. stock trendline breakdownMarket Growth Summary & Free Low Drawdown Momentum Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Greenwich LifeSciences Inc. stock outlook for YEAR2025 Price Targets & Technical Pattern Based Buy Signals - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 01:24:34 - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Greenwich LifeSciences expands breast cancer trial to Belgium By Investing.com - Investing.com Australia

Oct 02, 2025
pulisher
Oct 02, 2025

Greenwich LifeSciences expands breast cancer trial to Belgium - Investing.com India

Oct 02, 2025
pulisher
Oct 02, 2025

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium - The Manila Times

Oct 02, 2025
pulisher
Oct 02, 2025

Greenwich LifeSciences Expands FLAMINGO-01 Clinical Trial to Belgium for Breast Cancer Immunotherapy Research - Quiver Quantitative

Oct 02, 2025
pulisher
Oct 02, 2025

Major Breast Cancer Trial Expansion: Greenwich LifeSciences Adds Belgium to Global Phase III Study - Stock Titan

Oct 02, 2025
pulisher
Oct 01, 2025

How to use a screener to detect Greenwich LifeSciences Inc. breakoutsMarket Growth Review & Step-by-Step Trade Execution Guides - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial - Sahm

Oct 01, 2025
pulisher
Oct 01, 2025

Greenwich LifeSciences expands breast cancer trial to Portugal By Investing.com - Investing.com Nigeria

Oct 01, 2025
pulisher
Sep 30, 2025

Greenwich Lifesciences announces addition of Portugal to Flamingo-01 clinical trial - MarketScreener

Sep 30, 2025
pulisher
Sep 30, 2025

Greenwich LifeSciences expands breast cancer trial to Portugal - Investing.com India

Sep 30, 2025
pulisher
Sep 30, 2025

Greenwich LifeSciences Expands FLAMINGO-01 Clinical Trial to Portugal for Breast Cancer Immunotherapy - Quiver Quantitative

Sep 30, 2025
pulisher
Sep 30, 2025

9,065 Annual Breast Cancer Cases: Greenwich LifeSciences Expands Critical Phase III Trial to Portugal - Stock Titan

Sep 30, 2025
pulisher
Sep 30, 2025

What drives Greenwich LifeSciences Inc stock priceDouble Top/Bottom Patterns & Outperform With Our Smart Trading Calculator - earlytimes.in

Sep 30, 2025
pulisher
Sep 29, 2025

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel's holdings dropped 12% in value as a result of the recent pullback - simplywall.st

Sep 29, 2025
pulisher
Sep 29, 2025

HER2-Positive Breast Cancer Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Roche Pharma AG, Dizal Pharma, Greenwich LifeSciences, Ambrx - Barchart.com

Sep 29, 2025
pulisher
Sep 29, 2025

Exit strategy if you’re trapped in Greenwich LifeSciences Inc.Market Trend Report & Growth-Oriented Investment Plans - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

How to use Fibonacci retracement on Greenwich LifeSciences Inc.Weekly Gains Summary & Safe Capital Allocation Plans - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

Greenwich LifeSciences expands breast cancer trial to Ireland - MSN

Sep 28, 2025
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):